Elevation of blood pressure induced by high-dose milnacipran

Human Psychopharmacology

Volumn 17, Issue 8, 2002, Pages 431-

  Yoshida, Keizo ^a   Higuchi, Hisashi ^b   Takahashi, Hitoshi ^a   Shimizu, Tetsuo ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Omagari City Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BROTIZOLAM; MILNACIPRAN; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ADULT; APPETITE DISORDER; CASE REPORT; CONCENTRATION LOSS; DRUG MEGADOSE; HUMAN; HYPERTENSION; INSOMNIA; LASSITUDE; LETTER; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL;

ADRENERGIC UPTAKE INHIBITORS; BLOOD PRESSURE; CYCLOPROPANES; DEPRESSIVE DISORDER, MAJOR; HUMANS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 0036906402     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.432     Document Type: Letter

References (5)

1. Caron J, Libersa C, Hazard JR, et al. 1993. Acute electrophysiological effects of intravenous milnacipran: a new antidepressant agent. Eur Neuropsychopharmacol 3: 493-500.
2. Guelfi J, White C, Hackett D, Guichoux J, Magni G. 1995. Effectiveness of venlafaxine, in patients hospitalized for major depression and melancholia. J Clin Psychiatry 56: 450-458.
3. Spencer CM, Wilde MI. 1998. Milnacipran: a review of its use in depression. Drugs 56: 405-427.
4. Thase M. 1998. Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. J Clin Psychiatry 59: 502-508.
5. von Frenckell R, Ansseau M, Serre C, Sutet P. 1990. Pooling two controlled comparisons of milnacipran (F2207) and amitriptyline in endogenous inpatients: a new approach in dose ranging studies. Int Clin Psychopharmacol 5: 49-56.